Business
ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken Institute and Richard Nixon Foundation "Cancer 2035: A Roadmap for the Future" Summit
CULVER CITY, Calif., February 23, 2026--ImmunityBio, Inc. (Nasdaq: IBRX), a commercial-stage biotechnology company pioneering next-generation immunotherapies, today announced that its Founder, Executive Chairman, and Global Chief Scientific and Medical Officer, Dr. Patrick Soon-Shiong, will participate as a featured speaker at "Cancer 2035: A Roadmap for the Future," a landmark summit co-hosted by the Milken Institute and the Richard Nixon Foundation in Washington, D.C. on February 23–24, 2026.
About this update from Immunitybio, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/65b58aa491cb0888947bcc9fe2eb2844"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/I48effmbe7Zjec7VscFwuw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/65b58aa491cb0888947bcc9fe2eb2844","width":480,"height":270}},"lazy":false},{"type":"text","content":"Dr. Soon-Shiong joins Nobel laureates, former NIH directors, and leading oncology pioneers in Washington, D.C. to chart a path toward defeating cancer by 2035, with the discussion streamed live at Cancer 2035: A Roadmap for the Future Summit","length":241,"tagName":"p","attribs":{}},{"type":"text","content":"CULVER CITY, Calif., February 23, 2026--(BUSINESS WIRE)--ImmunityBio, Inc. (Nasdaq: IBRX), a commercial-stage biotechnology company pioneering next-generation immunotherapies, today announced that its Founder, Executive Chairman, and Global Chief Scientific and Medical Officer, Dr. Patrick Soon-Shiong, will participate as a featured speaker at "Cancer 2035: A Roadmap for the Future," a landmark summit co-hosted by the Milken Institute and the Richard Nixon Foundation in Washington, D.C. on February 23–24, 2026.","length":526,"tagName":"p"},{"type":"text","content":"The event coincides with the 55th anniversary of the National Cancer Act, the landmark legislation signed by President Richard Nixon that transformed the nation’s approach to cancer research and set in motion decades of scientific and clinical progress. The summit convenes the foremost leaders in oncology, immunology, and health policy to examine how today’s scientific and technological capabilities can drive the next era of biomedical progress and dramatically reduce cancer mortality by 2035.","length":498,"tagName":"p"},{"type":"text","content":"Dr. Soon-Shiong will take the stage alongside a distinguished roster of speakers that represents an extraordinary convergence of scientific, medical, and policy leadership, including:","length":183,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dr. Jim Allison, Nobel Laureate and Regental Chair and Professor of Immunology at MD Anderson Cancer Center","length":107,"tagName":"p","attribs":{...